Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (114) 114
life sciences & biomedicine (113) 113
humans (90) 90
oncology (80) 80
female (36) 36
male (36) 36
cancer (35) 35
lung cancer (32) 32
lung neoplasms - drug therapy (32) 32
care and treatment (30) 30
carcinoma, non-small-cell lung - drug therapy (28) 28
antineoplastic agents - therapeutic use (27) 27
biological and medical sciences (26) 26
aged (25) 25
medical sciences (25) 25
middle aged (25) 25
adult (24) 24
lung cancer, non-small cell (24) 24
tumors (23) 23
treatment outcome (21) 21
immunotherapy (20) 20
research (20) 20
respiratory system (20) 20
antineoplastic combined chemotherapy protocols - therapeutic use (19) 19
chemotherapy (19) 19
health aspects (19) 19
medicine, research & experimental (18) 18
lung neoplasms - pathology (17) 17
medicine, general & internal (17) 17
non-small cell lung cancer (17) 17
animals (16) 16
carcinoma, non-small-cell lung - pathology (16) 16
antineoplastic agents (15) 15
clinical trials (15) 15
human medicine (15) 15
clinical trials as topic (13) 13
combined modality therapy (13) 13
health care sciences & services (13) 13
health policy & services (12) 12
lung neoplasms - therapy (12) 12
nsclc (12) 12
public, environmental & occupational health (12) 12
review (12) 12
antibodies, monoclonal - therapeutic use (11) 11
antineoplastic agents - pharmacology (11) 11
bevacizumab (11) 11
carcinoma, non-small-cell lung - therapy (11) 11
cetuximab (11) 11
disease-free survival (11) 11
drug therapy (11) 11
lung neoplasms - genetics (11) 11
medical ethics (11) 11
medical laboratory technology (11) 11
medicine, legal (11) 11
prognosis (11) 11
targeted therapy (11) 11
development and progression (10) 10
erlotinib (10) 10
hematology (10) 10
hematology, oncology and palliative medicine (10) 10
medicine & public health (10) 10
metastasis (10) 10
non-small-cell lung cancer (10) 10
pharmacology. drug treatments (10) 10
pneumology (10) 10
tumors of the respiratory system and mediastinum (10) 10
aged, 80 and over (9) 9
antimitotic agents (9) 9
antineoplastic combined chemotherapy protocols - adverse effects (9) 9
carcinoma, non-small-cell lung - genetics (9) 9
epidermal growth factor (9) 9
head and neck cancer (9) 9
pharmacology & pharmacy (9) 9
taxoids - administration & dosage (9) 9
antineoplastic agents - adverse effects (8) 8
cancer vaccines - therapeutic use (8) 8
carcinoma, non-small-cell lung - immunology (8) 8
docetaxel (8) 8
dosage and administration (8) 8
lung neoplasms - immunology (8) 8
lung neoplasms - metabolism (8) 8
patients (8) 8
physiological aspects (8) 8
protein kinase inhibitors - therapeutic use (8) 8
respiratory tract diseases (8) 8
survival analysis (8) 8
cancer vaccines (7) 7
carcinoma, non-small-cell lung - metabolism (7) 7
genetic aspects (7) 7
head and neck neoplasms - drug therapy (7) 7
pemetrexed (7) 7
research & experimental medicine (7) 7
squamous cell carcinoma (7) 7
usage (7) 7
analysis (6) 6
angiogenesis (6) 6
angiogenesis inhibitors - therapeutic use (6) 6
antineoplastic combined chemotherapy protocols - administration & dosage (6) 6
biochemistry & molecular biology (6) 6
biotechnology & applied microbiology (6) 6
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text In silico evaluation of DNA Damage Inducible Transcript 4 gene (DDIT4) as prognostic biomarker in several malignancies
by Pinto, Joseph A and Rolfo, Christian and Raez, Luis E and Prado, Alexandra and Araujo, Jhajaira M and Bravo, Leny and Fajardo, Williams and Morante, Zaida D and Aguilar, Alfredo and Neciosup, Silvia P and Mas, Luis A and Bretel, Denisse and Balko, Justin M and Gomez, Henry L
Scientific reports, ISSN 2045-2322, 12/2017, Volume 7, Issue 1, pp. 1526 - 11
Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | Neoplasms - metabolism | Prognosis | Transcription Factors - chemistry | TOR Serine-Threonine Kinases - metabolism | Humans | Treatment Outcome | Phosphatidylinositol 3-Kinases - metabolism | Sirolimus - pharmacology | Databases as Topic | Transcription Factors - metabolism | Signal Transduction - drug effects | Computer Simulation | Survival Analysis | Biomarkers, Tumor - metabolism | DNA Damage | TOR protein | Transcription | Myeloid leukemia | Lung cancer | DNA damage | Glioblastoma | Data processing | Breast cancer | Rapamycin | Tumor cell lines | Glioblastoma multiforme | Chemotherapy | Colon cancer | Medical prognosis | Skin | Colon | Acute myeloid leukemia | Gastric cancer | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Efficacy of Larotrectinib in TRK Fusion–Positive Cancers in Adults and Children
by Drilon, Alexander and Laetsch, Theodore W and Kummar, Shivaani and DuBois, Steven G and Lassen, Ulrik N and Demetri, George D and Nathenson, Michael and Doebele, Robert C and Farago, Anna F and Pappo, Alberto S and Turpin, Brian and Dowlati, Afshin and Brose, Marcia S and Mascarenhas, Leo and Federman, Noah and Berlin, Jordan and El-Deiry, Wafik S and Baik, Christina and Deeken, John and Boni, Valentina and Nagasubramanian, Ramamoorthy and Taylor, Matthew and Rudzinski, Erin R and Meric-Bernstam, Funda and Sohal, Davendra P.S and Ma, Patrick C and Raez, Luis E and Hechtman, Jaclyn F and Benayed, Ryma and Ladanyi, Marc and Tuch, Brian B and Ebata, Kevin and Cruickshank, Scott and Ku, Nora C and Cox, Michael C and Hawkins, Douglas S and Hong, David S and Hyman, David M
The New England journal of medicine, ISSN 0028-4793, 02/2018, Volume 378, Issue 8, pp. 731 - 739
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Protein Kinases - genetics | Pyrazoles - therapeutic use | Protein Kinases - analysis | Humans | Middle Aged | Kaplan-Meier Estimate | Child, Preschool | Infant | Male | Antineoplastic Agents - therapeutic use | Neoplasms - drug therapy | Oncogene Proteins, Fusion - analysis | Young Adult | Disease-Free Survival | Neoplasms - chemistry | Pyrimidines - therapeutic use | Adolescent | Receptor Protein-Tyrosine Kinases - antagonists & inhibitors | Adult | Female | Aged | Child | Antimitotic agents | Treatment outcome | Safety and security measures | Analysis | Dosage and administration | Diagnosis | Antineoplastic agents | Cancer | Medical research | Inhibitor drugs | Tropomyosin | Oncology | Survival | Patients | Cancer therapies | Children & youth | Antitumor activity | Children | Drug dosages | Tumors | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Recommendations for detection, prioritization, and treatment of thoracic oncology patients during the COVID‐19 pandemic: the THOCOoP cooperative group
by Arrieta, Oscar and Cardona, Andrés F and Lara-Mejía, Luis and Heredia, David and Barrón, Feliciano and Zatarain-Barrón, Zyanya Lucia and Lozano, Francisco and de Lima, Vladmir Cordeiro and Maldonado, Federico and Corona-Cruz, Francisco and Ramos, Maritza and Cabrera, Luis and Martin, Claudio and Corrales, Luis and Cuello, Mauricio and Arroyo-Hernández, Marisol and Aman, Enrique and Bacon, Ludwing and Baez, Renata and Benitez, Sergio and Botero, Antonio and Burotto, Mauricio and Caglevic, Christian and Ferraris, Gustavo and Freitas, Helano and Kaen, Diego Lucas and Lamot, Sebastián and Lyons, Gustavo and Mas, Luis and Mata, Andrea and Mathias, Clarissa and Muñoz, Alvaro and Patane, Ana Karina and Oblitas, George and Pino, Luis and Raez, Luis E and Remon, Jordi and Rojas, Leonardo and Rolfo, Christian and Ruiz-Patiño, Alejandro and Samtani, Suraj and Viola, Lucia and Viteri, Santiago and Rosell, Rafael
Critical reviews in oncology/hematology, ISSN 1040-8428, 09/2020, Volume 153, pp. 103033 - 103033
COVID-19 | Recommendations | Personal protective equipment | Health systems | Thoracic oncology | Lung cancer | Oncology | Life Sciences & Biomedicine | Hematology | Science & Technology | Coronavirus Infections - prevention & control | Thoracic Neoplasms - therapy | Humans | Pandemics - prevention & control | Patient Care - standards | Coronavirus Infections - transmission | Pneumonia, Viral - transmission | SARS-CoV-2 | Coronavirus | Societies, Medical | Coronavirus Infections - epidemiology | Coronavirus Infections - virology | Pneumonia, Viral - epidemiology | Pneumonia, Viral - prevention & control | Thoracic Neoplasms - complications | Betacoronavirus | Pneumonia, Viral - virology | Epidemics | Care and treatment | Research | Oncology, Experimental | Cancer | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Scientific publications in cancer: in Latin America, strong scientific networks increase productivity (the TENJIN study)
by Ruiz-Patiño, Alejandro and Cardona, Andrés Felipe and Arrieta, Oscar and Rolfo, Christian and Gómez, Henry L and Raez, Luis E and Lopes, Gilberto and Zatarain-Barrón, Zyanya Lucia and Ricaurte, Luisa and Zamudio-Molano, Nataly and Rangel, Valentina and Oviedo, Juan and Solano, Maria Paula and Rojas, Leonardo and Corrales, Luis and Martín, Claudio and Mas, Luis and Cuello, Mauricio and Barrón, Feliciano and Otero, Jorge and Carranza, Hernán and Vargas, Carlos and Rosell, Rafael
Journal of clinical epidemiology, ISSN 0895-4356, 10/2020, Volume 126, pp. 1 - 8
Scholarly communication | Publications | Bibliometrics | Neoplasms | Latin America | Health Care Sciences & Services | Public, Environmental & Occupational Health | Life Sciences & Biomedicine | Science & Technology | Research | Analysis | Oncology, Experimental | Cancer | Productivity | Medical research | Networking | Authorship | Research & development--R&D | Mortality | Socio-economic aspects | Social factors | Regression analysis | Socioeconomics | Scientific papers | Literature reviews | Variables | Authoring | Multiple regression models | Publishing | Collaboration | Socioeconomic data | Documents | Trends | Sociodemographics | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Immunotherapy at any line of treatment improves survival in patients with advanced metastatic non‐small cell lung cancer (NSCLC) compared with chemotherapy (Quijote‐CLICaP)
by Ruiz‐Patiño, Alejandro and Arrieta, Oscar and Cardona, Andrés F and Martín, Claudio and Raez, Luis E and Zatarain‐Barrón, Zyanya L and Barrón, Feliciano and Ricaurte, Luisa and Bravo‐Garzón, María A and Mas, Luis and Corrales, Luis and Rojas, Leonardo and Lupinacci, Lorena and Perazzo, Florencia and Bas, Carlos and Carranza, Omar and Puparelli, Carmen and Rizzo, Manglio and Ruiz, Rossana and Rolfo, Christian and Archila, Pilar and Rodríguez, July and Sotelo, Carolina and Vargas, Carlos and Carranza, Hernán and Otero, Jorge and Pino, Luis E and Ortíz, Carlos and Laguado, Paola and Rosell, Rafael and CLICaP and on behalf of the CLICaP
Thoracic cancer, ISSN 1759-7706, 02/2020, Volume 11, Issue 2, pp. 353 - 361
Adult | lung neoplasms | programmed cell death 1 receptor/antagonists & inhibitors | immunotherapy | neoplasms/drug therapy | Respiratory System | Oncology | Life Sciences & Biomedicine | Science & Technology | Disease | Lung cancer | Histology | Metastasis | Patients | Cancer therapies | Studies | Survival analysis | Chemotherapy | Immunotherapy | Response rates | Fatalities | Mutation | Hispanics | Index Medicus | programmed cell death 1 receptor | drug therapy | neoplasms | Original | antagonists & inhibitors
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Anaphylactic Shock and Cardiac Arrest Secondary to Aprepitant
by Rosas, Daniel and Raez, Luis E
American journal of therapeutics, ISSN 1075-2765, 08/2020, Volume Publish Ahead of Print, Issue 6, pp. e640 - e642
Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text A phase I dose-escalation trial of 2-deoxy-d-glucose alone or combined with docetaxel in patients with advanced solid tumors
by Raez, Luis E and Raez, Luis E and Papadopoulos, Kyriakos and Papadopoulos, Kyriakos and Ricart, Alejandro D and Ricart, Alejandro D and Chiorean, E Gabriella and Chiorean, E Gabriella and DiPaola, Robert S and DiPaola, Robert S and Stein, Mark N and Stein, Mark N and Rocha Lima, Caio M and Rocha Lima, Caio M and Schlesselman, James J and Schlesselman, James J and Tolba, Khaled and Tolba, Khaled and Langmuir, Virginia K and Langmuir, Virginia K and Kroll, Stewart and Kroll, Stewart and Jung, Donald T and Jung, Donald T and Kurtoglu, Metin and Kurtoglu, Metin and Rosenblatt, Joseph and Rosenblatt, Joseph and Lampidis, Theodore J and Lampidis, Theodore J
Cancer chemotherapy and pharmacology, ISSN 0344-5704, 2/2013, Volume 71, Issue 2, pp. 523 - 530
2-Deoxy- d -Glucose | Phase I | Head and neck cancers | Medicine & Public Health | Lung cancer | Docetaxel | Oncology | Cancer Research | Breast cancer | Pharmacology/Toxicology | 2-Deoxy-d-Glucose | Pharmacology & Pharmacy | Life Sciences & Biomedicine | Science & Technology | Gynecology. Andrology. Obstetrics | Mammary gland diseases | Pharmacology. Drug treatments | Tumors of the respiratory system and mediastinum | Biological and medical sciences | Multiple tumors. Solid tumors. Tumors in childhood (general aspects) | Medical sciences | Antineoplastic agents | Tumors | Pneumology | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Blood Glucose - analysis | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Electrocardiography - drug effects | Male | Neoplasms - drug therapy | Deoxyglucose - therapeutic use | Taxoids - administration & dosage | Taxoids - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Deoxyglucose - adverse effects | Aged, 80 and over | Deoxyglucose - administration & dosage | Adult | Female | Aged | Taxoids - adverse effects | Complications and side effects | Glucose metabolism | Care and treatment | Hyperglycemia | Clinical trials | Nausea | Glucose | Cells | Dextrose | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Review of the Agnostic-Type Treatment Approach: Treating Cancer by Mutations, Not by Location
by Rosas, Daniel and Raez, Luis E
Oncology and therapy, ISSN 2366-1070, 06/2020, Volume 8, Issue 1, pp. 59 - 66
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Phase III randomized trial of induction chemotherapy in patients with N2 or N3 locally advanced head and neck cancer
by Cohen, Ezra E.W and Karrison, Theodore G and Kocherginsky, Masha and Mueller, Jeffrey and Egan, Robyn and Huang, Chao H and Brockstein, Bruce E and Agulnik, Mark B and Mittal, Bharat B and Yunus, Furhan and Samant, Sandeep and Raez, Luis E and Mehra, Ranee and Kumar, Priya and Ondrey, Frank and Marchand, Patrice and Braegas, Bettina and Seiwert, Tanguy Y and Villaflor, Victoria M and Haraf, Daniel J and Vokes, Everett E
Journal of clinical oncology, ISSN 0732-183X, 09/2014, Volume 32, Issue 25, pp. 2735 - 2743
Life Sciences & Biomedicine | Oncology | Science & Technology | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Induction Chemotherapy | Male | Carcinoma, Squamous Cell - radiotherapy | Chemoradiotherapy | Cisplatin - administration & dosage | Squamous Cell Carcinoma of Head and Neck | Fluorouracil - administration & dosage | Fluorouracil - adverse effects | Adult | Female | Taxoids - adverse effects | Docetaxel | Head and Neck Neoplasms - drug therapy | Hydroxyurea - administration & dosage | Survival Rate | Head and Neck Neoplasms - radiotherapy | Taxoids - administration & dosage | Carcinoma, Squamous Cell - drug therapy | Hydroxyurea - adverse effects | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Cisplatin - adverse effects | Aged | Index Medicus | Brazil | ORIGINAL REPORTS | Hnc6
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Cisplatin and Radiotherapy With or Without Erlotinib in Locally Advanced Squamous Cell Carcinoma of the Head and Neck: A Randomized Phase II Trial
by Renato G. Martins and Upendra Parvathaneni and Julie E. Bauman and Anand K. Sharma and Luis E. Raez and Michael A. Papagikos and Furhan Yunus and Brenda F. Kurland and Keith D. Eaton and Jay J. Liao and Eduardo. Mendez and Neal Futran and David X. Wang and Xiaoyu Chai and Sarah G. Wallace and Melissa Austin and Rodney Schmidt and D. Neil Hayes
Journal of clinical oncology, ISSN 0732-183X, 04/2013, Volume 31, Issue 11, pp. 1415 - 1421
Life Sciences & Biomedicine | Oncology | Science & Technology | Biological and medical sciences | Multiple tumors. Solid tumors. Tumors in childhood (general aspects) | Medical sciences | Otorhinolaryngology. Stomatology | Otorhinolaryngology (head neck, general aspects and miscellaneous) | Tumors | Erlotinib Hydrochloride | Receptor, Epidermal Growth Factor - genetics | Chemoradiotherapy - adverse effects | Carcinoma, Squamous Cell - genetics | Carcinoma, Squamous Cell - pathology | Humans | Male | Pain - chemically induced | Cisplatin - administration & dosage | Exanthema - chemically induced | Female | Quinazolines - administration & dosage | Chemoradiotherapy - methods | Drug Administration Schedule | Head and Neck Neoplasms - therapy | Carcinoma, Squamous Cell - therapy | In Situ Hybridization, Fluorescence | Treatment Outcome | Remission Induction | Head and Neck Neoplasms - pathology | Disease-Free Survival | Cisplatin - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Quinazolines - adverse effects | Cisplatin - adverse effects | Receptor, Epidermal Growth Factor - antagonists & inhibitors | Head and Neck Neoplasms - genetics | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Exosome-based detection of EGFR T790M in plasma from non–small cell lung cancer patients
by Castellanos-Rizaldos, Elena and Grimm, Dominik G and Tadigotla, Vasisht and Hurley, James and Healy, John and Neal, Patricia L and Sher, Mia and Venkatesan, Raajdeep and Karlovich, Chris and Raponi, Mitch and Krug, Anne and Noerholm, Mikkel and Tannous, Jihane and Tannous, Bakhos A and Raez, Luis E and Skog, Johan K
Clinical cancer research, ISSN 1078-0432, 06/2018, Volume 24, Issue 12, pp. 2944 - 2950
Life Sciences & Biomedicine | Oncology | Science & Technology | Tyrosine | Epidermal growth factor receptors | Laboratories | Lung cancer | Non-small cell lung carcinoma | Ribonucleic acid--RNA | Patients | Sensitivity | Epidermal growth factor | Biopsy | Experimental design | Alleles | Mutation | Protein-tyrosine kinase | Deoxyribonucleic acid--DNA | Cancer | Tumors | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text Entinostat (SNDX-275) for the treatment of non-small cell lung cancer
by Ruiz, Rossana and Raez, Luis E and Rolfo, Christian
Expert opinion on investigational drugs, ISSN 1354-3784, 08/2015, Volume 24, Issue 8, pp. 1101 - 1109
non-small cell lung cancer | entinostat | histone deacetylase | epigenetics | Epigenetics | Histone deacetylase | Entinostat | Non-small cell lung cancer | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Carcinoma, Non-Small-Cell Lung - pathology | Lung Neoplasms - genetics | Lung Neoplasms - drug therapy | Carcinoma, Non-Small-Cell Lung - genetics | Epigenesis, Genetic | Humans | Lung Neoplasms - pathology | Antineoplastic Agents - therapeutic use | Molecular Targeted Therapy | Pyridines - adverse effects | Animals | Benzamides - therapeutic use | Antineoplastic Agents - adverse effects | Histone Deacetylase Inhibitors - pharmacology | Antineoplastic Agents - pharmacology | Benzamides - pharmacology | Histone Deacetylase Inhibitors - therapeutic use | Pyridines - pharmacology | Carcinoma, Non-Small-Cell Lung - drug therapy | Benzamides - adverse effects | Histone Deacetylase Inhibitors - adverse effects | Pyridines - therapeutic use | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights